A Study to Evaluate SSGJ-707 in Advanced Gynecologic Cancer Patients

Clinical trial NCT06522828 · RECRUITING

Trial details

NCT number: NCT06522828
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced/recurrent Endometrial Cancer and Platinum-resistant Ovarian Cancer

Start date: 2024-10-10
Primary completion: 2025-08-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.